Supernus Pharmaceuticals
SUPN
#4494
Rank
NZ$4.42 B
Marketcap
NZ$76.03
Share price
1.26%
Change (1 day)
-11.19%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Net assets

Net assets on the balance sheet as of June 2026 : NZ$1.83 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company has NZ$1.83 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Supernus Pharmaceuticals - Net assets on balance sheet (from 2009 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$NZ$1.83 B-0.18%
2024-12-31$NZ$1.83 B26.03%
2023-12-31$NZ$1.45 B4.4%
2022-12-31$NZ$1.39 B16.86%
2021-12-31$NZ$1.19 B15.7%
2020-12-31$NZ$1.03 B16.76%
2019-12-31$NZ$0.88 B30.91%
2018-12-31$NZ$0.67 B79.32%
2017-12-31$NZ$0.37 B36.05%
2016-12-31$NZ$0.27 B115.28%
2015-12-31$NZ$0.12 B147.55%
2014-12-31$NZ$51.94 M27.56%
2013-12-31$NZ$40.72 M-41.81%
2012-12-31$NZ$69.98 M478.4%
2011-12-31$NZ$12.09 M-121.06%
2010-12-31$-NZ$57.45 Million577.8%
2009-12-31$-NZ$8.48 Million-27.1%
2008-12-31$-NZ$11.63 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
NZ$151.40 B 8,139.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$93.90 B 5,010.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$60.36 B 3,185.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$39.77 B 2,064.31%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
NZ$11.40 B 520.65%๐Ÿ‡บ๐Ÿ‡ธ USA